Bart W. Halstead

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• AstraZeneca (United States)14.4%
• China Pharmaceutical University10.7%
• AstraZeneca (United Kingdom)8.5%
• Takeda (Japan)7.8%
• University of North Carolina at Chapel Hill7.4%
• Bayer (Germany)7.4%
• Other43.7%

Fields

• Biochemistry, Genetics and Molecular Biology50%
• Medicine47.8%
• Immunology and Microbiology2.2%

Topics

• Cancer-related Molecular Pathways22.1%
• Protein Degradation and Inhibitors18.6%
• Ubiquitin and proteasome pathways15%
• Advanced Breast Cancer Therapies12.4%
• Chronic Lymphocytic Leukemia Research5.3%
• Histone Deacetylase Inhibitors Research5.3%
• Other21.2%